Hlx homeobox transcription factor negatively regulates interferon-γ production in monokine-activated natural killer cells

被引:22
作者
Becknell, Brian
Hughes, Tiffany L.
Freud, Aharon G.
Blaser, Bradley W.
Yu, Jianhua
Trotta, Rossana
Mao, Hsiaoyin C.
de Jesus, Marie L. Caligiuri
Alghothani, Mohamad
Benson, Don M., Jr.
Lehman, Amy
Jarjoura, David
Perrotti, Danilo
Bates, Michael D.
Caligiuri, Michael A.
机构
[1] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Integrated Biomed Sci Grp Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA
[5] Ohio State Univ, Dept Epidemiol & Biometr, Columbus, OH 43210 USA
[6] Ohio State Univ, Human Canc Genet Program, Dept Internal Med, Coll Med & Publ Hlth, Columbus, OH 43210 USA
[7] Univ Cincinnati, Coll Med, Div Gastroenterol Hepatol & Nutr, Cincinnati Childrens Hosp Med Ctr,Dept Pediat, Cincinnati, OH USA
[8] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1182/blood-2006-10-050096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural killer (NK) cells contribute to host immunity, including tumor surveillance, through the production of interferon gamma (IFN-gamma). Although there is some knowledge about molecular mechanisms that Induce IFN-gamma in NK cells, considerably less is known about the mechanisms that reduce its expression. Here, we investigate the role of the Hlx transcription factor in IFN-gamma production by NK cells. Hlx expression is induced in monokine-activated NK cells, but with delayed kinetics compared to IFN-gamma. Ectopic Hlx expression decreases IFN-gamma synthesis in primary human NK cells and IFN-gamma promoter activity in an NK-like cell line. Hlx protein levels inversely correlate with those of STAT4, a requisite factor for optimal IFN-gamma transcription. Mechanistically, we provide evidence indicating that Hlx overexpression accelerates dephosphorylation and proteasome-dependent degradation of the active Y693-phosphorylated form of STAT4. Thus, Hlx expression in activated NK cells temporally controls and limits the monokine-induced production of IFN-gamma, in part through the targeted depletion of STAT4. (Blood. 2007; 109:2481-2487).
引用
收藏
页码:2481 / 2487
页数:7
相关论文
共 39 条
  • [1] Barbulescu K, 1998, J IMMUNOL, V160, P3642
  • [2] Comparative genomics of the Hlx homeobox gene and protein:: Conservation of structure and expression from fish to mammals
    Bates, MD
    Well, JM
    Venkatesh, B
    [J]. GENE, 2005, 352 : 45 - 56
  • [3] Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector
    Becknell, B
    Trotta, R
    Yu, JH
    Ding, W
    Mao, HC
    Hughes, T
    Marburger, T
    Caligiuri, MA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 296 (1-2) : 115 - 123
  • [4] Helper T cell differentiation is controlled by the cell cycle
    Bird, JJ
    Brown, DR
    Mullen, AC
    Moskowitz, NH
    Mahowald, MA
    Sider, JR
    Gajewski, TF
    Wang, CR
    Reiner, SL
    [J]. IMMUNITY, 1998, 9 (02) : 229 - 237
  • [5] The immunological and genetic basis of inflammatory bowel disease
    Bouma, G
    Strober, W
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) : 521 - 533
  • [6] A distal region in the interferon-γ gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2
    Bream, JH
    Hodge, DL
    Gonsky, R
    Spolski, R
    Leonard, WJ
    Krebs, S
    Targan, S
    Morinobu, A
    O'Shea, JJ
    Young, HA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) : 41249 - 41257
  • [7] IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-γ expression in murine NK cells
    Bream, JH
    Curiel, RE
    Yu, CR
    Egwuagu, CE
    Grusby, MJ
    Aune, TM
    Young, HA
    [J]. BLOOD, 2003, 102 (01) : 207 - 214
  • [8] Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset
    Cooper, MA
    Fehniger, TA
    Turner, SC
    Chen, KS
    Ghaheri, BA
    Ghayur, T
    Carson, WE
    Caligiuri, MA
    [J]. BLOOD, 2001, 97 (10) : 3146 - 3151
  • [9] Di Noto R, 2001, LEUKEMIA, V15, P1641
  • [10] DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582